Pay in 4 interest-free payments of $5.19 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
What are the primary research applications for BPC-157
CJC-1295 / Ipamorelin Strength: 10 mg / 10 mg A higher-strength option for patients seeking an expanded protocol under provider guidance
Research-Use Labelling and Canadian Compliance Requirements Canadian regulatory framing for injectable peptides has tightened throughout 2025 and 2026, and BPC-157 in particular has been named in multiple Health Canada advisories
Toxicol Appl Pharmacol
NMDA Receptor Modulation Mechanism MK-801 studies (MK-801 is a more selective NMDA antagonist) showed BPC-157 counteracted locomotion abnormalities, stereotyped sniffing, and ataxia
US$ 28.93
US$ 25.08
US$ 20.52
US$ 24.42
